2021 Latest Design Rapid Diagnostic Test Antigen - KaiBiLi COVID-19 IgG/IgM – Genesis
2021 Latest Design Rapid Diagnostic Test Antigen - KaiBiLi COVID-19 IgG/IgM – Genesis Detail:
Introduction
The KaiBiLiTM COVID-19 IgG/IgM Rapid Test Device is a lateral flow chromatographic immunoassay for the qualitative detection of IgG and IgM antibodies to 2019- Novel Coronavirus in human whole blood, serum or plasma specimen. It is only used as a supplementary detection indicator for new suspected cases of negative coronavirus nucleic acid detection or in conjunction with nucleic acid detection in the diagnosis of suspected cases. It cannot be used as a basis for the diagnosis and exclusion of pneumonitis infected by 2019-nCoV infection. It is not suitable for general population screening.
Any reactive specimen with the COVID-19 IgG/IgM Rapid Test Device must be confirmed with alternative testing method(s) and clinical findings. A positive test result requires further confirmation. A negative results do not preclude acute 2019-nCoV infection. If acute infection is suspected, direct testing for COVID-19 antigen is necessary. False positive results for COVID-19 IgG/IgM Rapid Test may occur due to cross-reactivity from preexisting antibodies or other possible causes. Due to the risk of false positive results, confirmation of positive results should be considered using second, different IgG or IgM assay.
Detection
The COVID-19 IgG/IgM Rapid Test Device (Whole Blood/Serum/Plasma) is a qualitative lateral flow immunechromatographic assay for the detection of IgG and IgM antibodies to 2019-nCoV in whole blood, serum or plasma specimen.
Specimen
IgG and IgM antibodies to 2019 nCoV in whole blood, serum or plasma specimen.
Accuracy
IgG Result:
Relative Sensitivity: 98.28%
Relative Specificity: 97.01%
Accuracy: 97.40%
IgM Result:
Relative Sensitivity: 82.76%
Relative Specificity: 98.51%
Accuracy: 93.75%
Time to Results
Read results at 15minutes and no more than 30 minutes.
Kit storage conditions
2~30°C.
Contents
| P231133 | P231134 | P231135 | |
| COVID-19 IgG/IgM test device | 40 pcs | 30 pcs | 1 each |
| Sample buffer | 5mL/Bot.
1Bot |
80μl/vial
30 vial |
80μl/vial
1 vial |
| Capillary dropper* | 40 pcs | 30 pcs | 1 each |
| Package insert | 1 each | 1 each | 1 each |
*Capillary dropper: For whole blood.
Ordering Information
|
Product |
Cat.No. |
Contents |
| KaiBiLiTM COVID-19 IgG/IgM | P231133 | 40 Tests |
| KaiBiLiTM COVID-19 IgG/IgM | P231134 | 30 Tests |
| KaiBiLiTM COVID-19 IgG/IgM | P231135 | 1 Tests |
Product detail pictures:
Related Product Guide:
Our purpose is to fulfill our clients by offering golden company, great price and premium quality for 2021 Latest Design Rapid Diagnostic Test Antigen - KaiBiLi COVID-19 IgG/IgM – Genesis , The product will supply to all over the world, such as: Chile, Afghanistan, Tanzania, They are sturdy modeling and promoting effectively all over the world. Never ever disappearing major functions within a quick time, it's a have to in your case of fantastic good quality. Guided by the principle of Prudence, Efficiency, Union and Innovation. the corporation. ake an excellent efforts to expand its international trade, raise its organization. rofit and raise its export scale. We've been confident that we've been going to have a bright prospect and to be distributed all over the world in the years to come.
By Barbara from Madrid - 2017.11.01 17:04
The company comply with the contract strict, a very reputable manufacturers, worthy a long-term cooperation.
By Laura from Serbia - 2018.06.05 13:10
